⭐ Start off 2025 with a powerful boost to your portfolio: January’s freshest AI-picked stocksUnlock stocks

Arteris director Saiyed Atiq Raza sells $429,535 in stock

Published 12/30/2024, 04:36 PM
AIP
-

CAMPBELL, CA—Saiyed Atiq Raza, a director of Arteris, Inc. (NASDAQ:AIP), recently sold 41,439 shares of the company's common stock, according to a filing with the Securities and Exchange Commission. The shares were sold at a weighted average price of $10.37, yielding a total transaction value of approximately $429,535. The transaction comes as the stock trades near its 52-week high of $10.70, having delivered an impressive 74% return year-to-date.

This sale was conducted under a pre-established 10b5-1 trading plan, which Raza adopted on June 6, 2024. Following the transaction, Raza holds 690,121 shares indirectly through the Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust. Additionally, he directly owns 19,287 shares of Arteris common stock. InvestingPro subscribers can access detailed insider trading patterns and 12+ additional key insights about AIP.

Investors often scrutinize such transactions for insight into insider sentiment, although the use of a 10b5-1 plan indicates that the sale was pre-planned. Arteris, headquartered in Campbell, California, operates in the semiconductor sector, providing network-on-chip interconnect IP solutions. The company maintains impressive gross profit margins of 89% and has a market capitalization of $413 million. According to InvestingPro's Fair Value analysis, the stock appears to be trading near its fair value.

In other recent news, Arteris Inc. reported a strong third quarter, with a focus on AI and automotive SoC. The company announced record annual contract value (ACV) plus royalties of $60.5 million, a year-over-year revenue increase of 11% to $14.7 million, and a positive free cash flow of $1.1 million. Arteris also secured a significant deal with one of the top five global tech companies and has received positive feedback on its new NoC Tiling product.

Looking ahead, the company forecasts Q4 2024 ACV plus royalties between $63 million to $67 million and full-year revenue projections for 2024 between $56.9 million and $57.9 million. However, despite the company's expansion into the microcontroller market, average selling prices (ASPs) are lower than for complex SoCs.

Arteris is also engaged with 10 out of the top 30 tech companies that are designing chips. The company's bookings for the period are estimated at $23 million to $24 million, reflecting typical seasonal trends with a stronger fourth quarter expected. These are among the recent developments in the company's operations.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.